from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3489/-

LFCtreatmentdescriptionclass of inhibitor

2.037

Amikacinug/mL Amikacintranslation

1.293

Cap5-10ug/mL Capreomycintranslation

1.544

Rox10-50 ug/mL Roxithromycintranslation

0.981

SM2-5 ug/mL Streptomycintranslation

1.932

Tet5-10 ug/mL Tetracyclinetranslation

-2.225

Rif0.2-5ug/mL Rifampicintranscription

-0.976

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.558

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.199

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.013

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.384

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.391

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.958

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.303

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.362

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.069

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.161

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.035

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.351

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.820

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.735

KCN5-20 ug/mL Potassium cyaniderespiration

0.410

NaN30.2-2 mM Sodium aziderespiration

0.236

Nigericin50 uM Nigericinrespiration

-0.495

TRC10-150 ug/mL Triclosanrespiration

-0.434

TRZ10-25 ug/mL Thioridazinerespiration

-0.224

Valinomycin0.5-10 uM Valinomycinrespiration

-0.132

ZnSO42 mM ZnSO4respiration

2.029

menadione6-10 ug/mL Menadionerespiration

-0.254

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.300

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.479

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.282

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.226

NRP_1Non-replicating persistence stage 1dosRassociated

0.615

Amp0.2mg/mL AmpicillincellWall

0.101

Cephalexin20-100 ug/mL CephalexincellWall

0.374

Cerulenin0.32-5 ug/mL CerulenincellWall

0.532

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.431

EMB10-20 ug/mL EthambutolcellWall

1.392

Eta12-40 ug/mL EthionamidecellWall

2.175

INH0.2-0.4 ug/mL IsoniazidcellWall

0.970

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.430

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.625

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.152

BZA0.12 mg/mL BenzamidearomaticAmides

-0.573

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.757

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.599

H2O24 mM hydrogen peroxideDNAdamaging

-0.519

Levo10 ug/mL LevofloxacinDNAdamaging

-0.244

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.977

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.123

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.827

UVUV-irradiationDNAdamaging

-0.728

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.266

Antimycin12.5-50 ug/mL Antimycin A?

-0.771

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.421

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.493

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.188

PA8240.2-2 ug/mL PA-824?

0.611

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.109

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.015

Verapamil50 uM Verapamil?

-0.098

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.680

methoxatin10-20 ug/mL Methoxatin?